|
Active Ingredient
|
DABIGATRAN
|
|
Therapeutic Class
|
DIRECT THROMBIN INHIBITORS
|
|
Indications
|
Dabigatran is a direct thrombin inhibitor. It is used for the prophylaxis of venous thromboembolism in patients undergoing orthopaedic surgery and the prevention of stroke and systemic embolisation in More ...
|
|
Caution
|
Dabigatran should not be used in patients who are at a high risk for bleeding. It is contraindicated for those patients who have mechanical prosthetic heart valves because of thromboembolism and major More ...
|
|
Dose Range
|
Prophylaxis of venous embolism after orthropaedic surgery: Adult: 18-74 years, 110mg to be taken 1-4 hours after surgery, followed by 220mg once daily for 9 days , to be taken 12-24 hours after initial dose. Adult: 75years and older 110mg to be taken afte
|
|
Drug Interactions
|
|
|
Pregnancy
|
|
|
Breast Feeding
|
|
